Biocept Inc. (BIOC) Fundamentals

Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
SHARE INFORMATION
Market CapUS$ 15.569.039
Shares Outstanding16.922.868
Float16.917.727
Percent Float99,97%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 61.248.999
Latest Fiscal EPSUS$ -0,19
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions64
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months240.973
Institutional Holdings Percent18,2%
Institutional Sold Previous 3 Months343.894
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months-
Insider Holdings Percent3,1
Insider Sold Previous 3 Months-
Insider Shares Owned520.177
TRADING INFO
52 Week HighUS$ 4,40
52 Week LowUS$ 0,72
52 Week High ChangeUS$ -76,17
21 Day Moving AverageUS$ 0,8958
21 Day Extended Moving AverageUS$ 0,893585
50 Day Moving AverageUS$ 0,9825
50 Day Extended Moving AverageUS$ 0,981603
200 Day Moving AverageUS$ 1,8389
200 Day Extended Moving AverageUS$ 1,8005
10 Day Average Volume73.430
20 Day Average Volume53.650
30 Day Average Volume56.513
50 Day Average Volume67.094
Alpha-0.050593
Beta0.7738
Standard Deviation0.353221
R20.012217
7 Day Price ChangeUS$ 0,15
7 Day Percent Change19,48%
21 Day Price ChangeUS$ -0,0116
21 Day Percent Change-1,25%
30 Day Price ChangeUS$ -0,18
30 Day Percent Change-16,36%
Month to Date Price ChangeUS$ -0,11
Month to Date Percent Change-10,68%
Quarter to Date Price ChangeUS$ -0,02
Quarter to Date Percent Change-2,13%
180 Day Price ChangeUS$ -1,31
180 Day Percent Change-58,74%
200 Day Price ChangeUS$ -1,09
200 Day Percent Change-54,23%
Year to Date Price ChangeUS$ -2,70
Year to Date Percent Change-74,59%

Biocept Inc. (BIOC) Key Ratios

PROFITABILITY
EBIT Margin-12,3%
EBITDA Margin-8,0%
Pre-Tax Profit Margin-345,9%
Profit Margin Count-12,06%
Gross Margin38,4%
Profit Margin TOT-12,06%
INCOME STATEMENTS
RevenueUS$ 51.390.644
Revenue Per ShareUS$ 3,0368
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book0,40
Total Debt To Equity0,30
Int Coverage-27,20
Current Ratio3,40
Leverage Ratio1,60
Quick Ratio3,10
Long Term Debt To Capital0,23
VALUATION MEASURES
PE Ratio-1,70
Enterprise ValueUS$ -44.727
Price to Sales0,302955
Price to Free Cash-17,10
PE High Last 5 Years-0,40
Price To Book0,40
Price To Cash Flow7,40
PE Low Last 5 Years-1,90
Price to Tangible Book0,40
MANAGEMENT EFFECTIVENESS
Receivables Turnover3,50
Invoice Turnover12,90
Assets Turnover1,00
Return Assets-14,97
Return on Equity-26,29
Return on Capital-18,04

Biocept Inc. (BIOC) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMayer Hoffman McCann P.C.
CEOSamuel D. Riccitelli
Emplyoees192
Last AuditUQ
CIK0001044378
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSMedical Laboratories(621511)
CONTACT INFO
Address9955 Mesa Rim Road
Suite 150
San Diego, CA 92121
Websitehttps://www.biocept.com
Facsimile+1 858 320-8225
Telephone+1 858 320-8200
Emailir@biocept.com
Seu Histórico Recente
NASDAQ
BIOC
Biocept
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220930 15:40:53